Johnson & Johnson (NYSE:JNJ) is included among the 14 Best Pharma Dividend Stocks to Buy in 2026. On December 26, Johnson & ...
As a result, finding a compatible dermatologist and solution to eczema is not just logistically difficult but often ...
Eczema is a common skin condition that causes itchiness, burning and dryness. Dry skin occurs when your skin loses too much ...
Skin condition flare-ups during the humid season are leading some individuals to avoid social events and celebrations.
Stocktwits on MSN
Johnson & Johnson terminates experimental eczema drug study after it fails to show benefit
The drug JNJ-5939 was being evaluated in the treatment of moderate to severe atopic dermatitis in a mid-stage study. ・JNJ, ...
Johnson & Johnson said on Friday it discontinued a mid-stage study of its experimental drug to treat patients with moderate ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback